← Evidence map

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Imipenem-relebactam for Treatment of Carbapenem-resistant Gram-negative Bacteria: Where Do We Stand on In Vitro Susceptibility Testing?

Maroun M SfeirPubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32634243